{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:03:27Z","timestamp":1761487407774},"reference-count":24,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.vaccine.2005.05.022","type":"journal-article","created":{"date-parts":[[2005,6,14]],"date-time":"2005-06-14T11:25:42Z","timestamp":1118748342000},"page":"5120-5126","source":"Crossref","is-referenced-by-count":12,"title":["Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers\u2019 diarrhoea in a randomised, double-blind, placebo-controlled study"],"prefix":"10.1016","volume":"23","author":[{"given":"E.M.S.","family":"Leyten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Soonawala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schultsz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.","family":"Ligthelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wijnands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.G.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.05.022_bib1","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/jama.249.9.1176","article-title":"Epidemiology of diarrhea in travellers","volume":"249","author":"Steffen","year":"1983","journal-title":"JAMA"},{"issue":"9224","key":"10.1016\/j.vaccine.2005.05.022_bib2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(00)02451-X","article-title":"Risk and aetiology of diarrhoea at various tourist destinations","volume":"356","author":"von Sonnenburg","year":"2000","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2005.05.022_bib3","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1093\/clinids\/8.Supplement_2.S109","article-title":"Travellers\u2019 diarrhea: National Institutes of Health Consenses Development Conference","volume":"8","author":"Gorbach","year":"1986","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2005.05.022_bib4","series-title":"Textbook of travel medicine and health","first-page":"151","article-title":"Travellers\u2019 diarrhea: epidemiology and clinical aspects","author":"Peltola","year":"2001"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2005.05.022_bib5","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/clinids\/12.Supplement_1.S73","article-title":"Epidemiology of travelers\u2019 diarrhea and relative importance of various pathogens","volume":"12","author":"Black","year":"1990","journal-title":"Rev Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2005.05.022_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/338834","article-title":"Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombassa), India (Goa), or Jamaica (Montego Bay)","volume":"185","author":"Jiang","year":"2002","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2005.05.022_bib7","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1086\/315121","article-title":"Improved detection of enterotoxigenic Escherichia coli among patients with travelers\u2019 diarrhea, by use of the polymerase chain reaction technique","volume":"180","author":"Caeiro","year":"1999","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2005.05.022_bib8","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0966-842X(96)10068-8","article-title":"Colonization factors of human enterotoxigenic Escherichia coli (ETEC)","volume":"4","author":"Gaastra","year":"1996","journal-title":"Trends Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2005.05.022_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.10.4.569","article-title":"Occurrence, distribution and association of O and H serogroups, colonization factor antigens, and toxins of eneterotoxigenic Escherichia Coli","volume":"10","author":"Wolf","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"10.1016\/j.vaccine.2005.05.022_bib10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0264-410X(93)90380-G","article-title":"Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine","volume":"11","author":"Ahren","year":"1993","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2005.05.022_bib11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","article-title":"Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxi-genic Escherichia coli: results of a large-scale field trial","volume":"158","author":"Clemens","year":"1988","journal-title":"J Infect Dis"},{"issue":"8778","key":"10.1016\/j.vaccine.2005.05.022_bib12","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/0140-6736(91)92590-X","article-title":"Prevention of travellers\u2019 diarrhea by oral B-subunit\/whole-cell cholera vaccine","volume":"338","author":"Peltola","year":"1991","journal-title":"Lancet"},{"issue":"8609","key":"10.1016\/j.vaccine.2005.05.022_bib13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(88)90120-1","article-title":"Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR","volume":"2","author":"Levine","year":"1988","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2005.05.022_bib14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0264-410X(90)90012-B","article-title":"Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults","volume":"8","author":"Cryz","year":"1990","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2005.05.022_bib15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/IAI.60.10.4430-4432.1992","article-title":"Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized placebo-controlled, double-blind crossover trial","volume":"60","author":"Kotloff","year":"1992","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2005.05.022_bib16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/infdis\/166.4.837","article-title":"Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR","volume":"166","author":"Tacket","year":"1992","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2005.05.022_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0264-410X(93)90019-T","article-title":"Live oral vaccines against cholera: an update","volume":"11","author":"Levine","year":"1993","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2005.05.022_bib18","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/ajcp\/96.3.364","article-title":"An evaluation of three commercial fecal transport systems for the recovery of enteric pathogens","volume":"96","author":"Mundy","year":"1991","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.vaccine.2005.05.022_bib19","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/infdis\/157.5.1008","article-title":"Travellers\u2019 diarrhea in West Africa and Mexico: fecal transport systems and liquid Bismuth subsalicylate for self-therapy.","volume":"157","author":"Steffen","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.05.022_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1574-6968.1984.tb01036.x","article-title":"Isolation of enteric pathogens from patients with travelers\u2019 diarrhea using fecal transport media","volume":"23","author":"Morgan","year":"1984","journal-title":"FEMS Lett"},{"issue":"10","key":"10.1016\/j.vaccine.2005.05.022_bib21","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1128\/JCM.32.10.2393-2397.1994","article-title":"Detection of enterotoxigenic Escherichia coli in stool samples by using nonradioactively labeled oligonucleotide DNA probes and PCR","volume":"32","author":"Schultsz","year":"1994","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.05.022_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1086\/314543","article-title":"Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group","volume":"179","author":"Savarino","year":"1999","journal-title":"J Infect Dis"},{"issue":"24","key":"10.1016\/j.vaccine.2005.05.022_bib23","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1056\/NEJM197606102942401","article-title":"Travellers\u2019 diarrhea in Mexico. A prospective study of physicians and family members attending a congress","volume":"294","author":"Merson","year":"1976","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2005.05.022_bib24","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/517812","article-title":"Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults","volume":"177","author":"Savarino","year":"1998","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0500544X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0500544X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T18:32:14Z","timestamp":1586284334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0500544X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":24,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0264410X0500544X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.05.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}